__NUXT_JSONP__("/drugs/Masitinib_Mesylate", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"The orally bioavailable mesylate salt of masatinib, a multi-targeted protein tyrosine kinase inhibitor with potential antineoplastic activity. Masitinib selectively binds to and inhibits both the wild-type and mutated forms of the stem cell factor receptor (c-Kit; SCFR); platelet-derived growth factor receptor (PDGFR); fibroblast growth factor receptor 3 (FGFR3); and, to a lesser extent, focal adhesion kinase (FAK). As a consequence, tumor cell proliferation may be inhibited in cancer cell types that overexpress these receptor tyrosine kinases (RTKs).",fdaUniiCode:"ZK89EG3A18",identifier:"C79831",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C1967"],synonyms:["4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)benzamide Mesylate","AB1010","MASITINIB MESYLATE",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FMasitinib_Mesylate",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Masitinib_Mesylate","Masitinib Mesylate","2021-10-30T13:45:27.943Z")));